Limba
|
Motavizumab (Anti-RSV-F) is a monoclonal antibody targeting human RSV (respiratory syncytial virus). It can be used in respiratory syncytial virus infection in high-risk infants research. MW :145.32 KD.
Price | 2.736,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Motavizumab (Anti-RSV-F) is a monoclonal antibody targeting human RSV (respiratory syncytial virus). It can be used in respiratory syncytial virus infection in high-risk infants research. MW :145.32 KD. |